Skip to main content
Kelly J. Lundberg
No Rating Available
(Learn About Our Rating System)

Kelly J. Lundberg, PhD

Languages spoken: English
  • Kelly is a licensed psychologist who is an Associate Professor and Director of Operations in the Department of Psychiatry at the University of Utah. Dr. Lundberg was the recipient of the Governor’s Award for Contributions to Substance Abuse Treatment and Anti-Violence in 1997 and was the 2006 recipient of the Treatment Award from the State Division of Substance Abuse and Mental Health. She has a statewide reputation as one of the leading experts in addictions and is sought throughout Utah for her teaching and consultative services.

    Specialties

  • Kelly is a licensed psychologist who is an Associate Professor and Director of Operations in the Department of Psychiatry at the University of Utah. Dr. Lundberg was the recipient of the Governor’s Award for Contributions to Substance Abuse Treatment and Anti-Violence in 1997 and was the 2006 recipient of the Treatment Award from the State Division of Substance Abuse and Mental Health. She has a statewide reputation as one of the leading experts in addictions and is sought throughout Utah for her teaching and consultative services.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Associate Professor (Clinical)
    Academic Divisions Adult Psychiatry

    Education history

    Internship Psychology - Veterans Affairs Medical Center Intern
    Doctoral Training Counseling Psychology - University of Iowa Ph.D.
    Graduate Training Clinical Psychology - Indiana University of Pennsylvania Master's
    Undergraduate Psychology - Northern Michigan University B.S.

    Selected Publications

    Journal Article

    1. Ulrich CM, Himbert C, Barnes CA, Boucher KM, Daniels B, Bandera VM, Ligibel JA, Wetter DW, Hess R, Kim J, Lundberg K, Mitzman B, Marcus R, Finlayson SRG, LaStayo PC, Varghese TK Jr (2026). Precision Exercise Effect on Fatigue and Function in Lung Cancer Surgery: A Randomized Clinical Trial. JAMA Surg, 160(5), 495-519. (Read full publication)
    2. Fritz JM, Gibson B, Wetter DW, Del Fiol G, Solis V, Ford I, Lundberg K, Thackeray A (2024). Use of implementation mapping in the planning of a hybrid type 1 pragmatic clinical trial: the BeatPain Utah study. Implement Sci Commun, 5(1), 3. (Read full publication)
    3. Fritz JM, Del Fiol G, Gibson B, Wetter DW, Solis V, Bennett E, Thackeray A, Goode A, Lundberg K, Romero A, Ford I, Stevens L, Siaperas T, Morales J, Yack M, Greene T (2022). BeatPain Utah: study protocol for a pragmatic randomised trial examining telehealth strategies to provide non-pharmacologic pain care for persons with chronic low back pain receiving care in federally qualified health centers. BMJ Open, 12(11), e067732. (Read full publication)
    4. Gibson B, Simonsen S, Barton J, Zhang Y, Altizer R, Lundberg K, Wetter DW (2021). Motivation and Problem Solving Versus Mobile 360° Videos to Promote Enrollment in the National Diabetes Prevention Program's Lifestyle Change Program Among People With Prediabetes: Protocol for a Randomized Trial. JMIR Res Protoc, 10(6), e28884. (Read full publication)
    5. Ulrich CM, Himbert C, Boucher K, Wetter DW, Hess R, Kim J, Lundberg K, Ligibel JA, Barnes CA, Rushton B, Marcus R, Finlayson SRG, LaStayo PC, Varghese TK (2018). Precision-Exercise-Prescription in patients with lung cancer undergoing surgery: rationale and design of the PEP study trial. BMJ Open, 8(12), e024672. (Read full publication)
    6. Hellem TL, Sung YH, Shi XF, Pett MA, Latendresse G, Morgan J, Huber RS, Kuykendall D, Lundberg KJ, Renshaw PF (2015). Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study. J Dual Diagn, 11(3-4), 189-202. (Read full publication)
    7. Sung YH, Yurgelun-Todd DA, Kondo DG, Shi XF, Lundberg KJ, Hellem TL, Huber RS, McGlade EC, Jeong EK, Renshaw PF (2015). Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects. Am J Drug Alcohol Abuse, 41(4), 281-9. (Read full publication)
    8. Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, Huber RS, Fiedler KK, Harrell RE, Nickerson BR, Kim SE, Jeong EK, Renshaw PF (2013). Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug Alcohol Depend, 129(1-2), 102-9. (Read full publication)
    9. Ravarino JM, Gardner MK, Hill RD, Lundberg K (2008). Effectiveness of pretreatment interim support group attendance in facilitating treatment enrollment among methamphetamine abusers. Addict Behav, 33(2), 336-41. (Read full publication)
    10. Burrow-Sanchez JJ, Lundberg KJ (2007). Readiness to change in adults waiting for publicly funded substance abuse treatment. Addict Behav, 32(1), 199-204. (Read full publication)

    Review

    1. Hellem TL, Lundberg KJ, Renshaw PF (2015). A review of treatment options for co-occurring methamphetamine use disorders and depression. [Review]. J Addict Nurs, 26(1), 14-23; quiz E1. (Read full publication)